Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022

BACKGROUND: US recommendations for COVID‐19 vaccine boosters have expanded in terms of age groups covered and numbers of doses recommended, whereas evolution of Omicron sublineages raises questions about ongoing vaccine effectiveness. METHODS: We estimated effectiveness of monovalent COVID‐19 mRNA b...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrie, Joshua G., King, Jennifer P., McClure, David L., Rolfes, Melissa A., Meece, Jennifer K., Pattinson, David, Neumann, Gabriele, Kawaoka, Yoshihiro, Belongia, Edward A., McLean, Huong Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975792/
https://www.ncbi.nlm.nih.gov/pubmed/36875208
http://dx.doi.org/10.1111/irv.13104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975792/
https://www.ncbi.nlm.nih.gov/pubmed/36875208
http://dx.doi.org/10.1111/irv.13104

Ejemplares similares